AI Evaluation of Stenosis on Coronary CT Angiography, Comparison With Quantitative Coronary Angiography and Fractional Flow Reserve: A CREDENCE Trial Substudy
- Author(s)
- William F. Griffin; Andrew D. Choi; Joanna S. Riess; Hugo Marques; Hyuk-Jae Chang; Jung Hyun Choi; Joon-Hyung Doh; Ae-Young Her; Bon-Kwon Koo; Chang-Wook Nam; Hyung-Bok Park; Sang-Hoon Shin; Jason Cole; Alessia Gimelli; Muhammad Akram Khan; Bin Lu; Yang Gao; Faisal Nabi; Ryo Nakazato; U. Joseph Schoepf; Roel S. Driessen; Michiel J. Bom; Randall Thompson; James J. Jang; Michael Ridner; Chris Rowan; Erick Avelar; Philippe Généreux; Paul Knaapen; Guus A. de Waard; Gianluca Pontone; Daniele Andreini; James P. Earls
- Keimyung Author(s)
- Nam, Chang Wook
- Department
- Dept. of Internal Medicine (내과학)
- Journal Title
- JACC Cardiovasc Imaging
- Issued Date
- 2023
- Volume
- 16
- Issue
- 2
- Keyword
- artificial intelligence; atherosclerosis; CCTA; coronary artery disease; coronary computed tomography; fractional flow reserve; quantitative coronary angiography
- Abstract
- Objectives:
The study compared the performance for detection and grading of coronary stenoses using artificial intelligence–enabled quantitative coronary computed tomography angiography (AI-QCT) analyses to core lab–interpreted coronary computed tomography angiography (CTA), core lab quantitative coronary angiography (QCA), and invasive fractional flow reserve (FFR).
Background:
Clinical reads of coronary CTA, especially by less experienced readers, may result in overestimation of coronary artery disease stenosis severity compared with expert interpretation. AI-based solutions applied to coronary CTA may overcome these limitations.
Methods:
Coronary CTA, FFR, and QCA data from 303 stable patients (64 ± 10 years of age, 71% male) from the CREDENCE (Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia) trial were retrospectively analyzed using an Food and Drug Administration–cleared cloud-based software that performs AI-enabled coronary segmentation, lumen and vessel wall determination, plaque quantification and characterization, and stenosis determination.
Results:
Disease prevalence was high, with 32.0%, 35.0%, 21.0%, and 13.0% demonstrating ≥50% stenosis in 0, 1, 2, and 3 coronary vessel territories, respectively. Average AI-QCT analysis time was 10.3 ± 2.7 minutes. AI-QCT evaluation demonstrated per-patient sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 94%, 68%, 81%, 90%, and 84%, respectively, for ≥50% stenosis, and of 94%, 82%, 69%, 97%, and 86%, respectively, for detection of ≥70% stenosis. There was high correlation between stenosis detected on AI-QCT evaluation vs QCA on a per-vessel and per-patient basis (intraclass correlation coefficient = 0.73 and 0.73, respectively; P < 0.001 for both). False positive AI-QCT findings were noted in in 62 of 848 (7.3%) vessels (stenosis of ≥70% by AI-QCT and QCA of <70%); however, 41 (66.1%) of these had an FFR of <0.8.
Conclusions:
A novel AI-based evaluation of coronary CTA enables rapid and accurate identification and exclusion of high-grade stenosis and with close agreement to blinded, core lab–interpreted quantitative coronary angiography. (Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia [CREDENCE]; NCT02173275).
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.